← Back to search

Coral Genomics

New clinical tests for managing autoimmune treatments.

Y CombinatorSummer 2018AcquiredHealthcareDrug Discovery and DeliveryGenomics

What they do

Problem

Autoimmune disease treatments are often chosen without reliable prediction of which therapy will work for a given patient, leading to non-response and unmet clinical need.

Solution

Coral Genomics develops clinical laboratory tests that integrate molecular, functional, and clinical data to predict optimal autoimmune therapies and identify non-responders.

Who it's for

Clinicians and healthcare systems treating autoimmune patients, via clinical laboratories that run the tests.

Founders

Atray Dixit
Founder

PhD from MIT and researched at Broad Institute

Jacob Borrajo
Founder

Company timeline

Similar startups